MedPath

Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States

Not Applicable
Recruiting
Conditions
No Condition
Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG
Registration Number
NCT07110688
Lead Sponsor
University of Southern California
Brief Summary

In this program, the investigators will develop novel multimodal neural-behavioral-physiological monitoring tools (software and hardware), and machine learning models for mental states within social processes and beyond. The tools consist of a multimodal skin-like wearable sensor for physiological and biochemical sensing; a conversational virtual human platform to evoke naturalistic social processes; audiovisual affect recognition software; synchronization tools; and machine learning methods to model the multimodal data. The investigators will demonstrate the tools in healthy subjects without neural recordings and in patients with drug-resistant epilepsy who already have intracranial EEG (iEEG) electrodes implanted based on clinical criteria for standard monitoring to localize seizures, which is unrelated to our study.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Positive and Negative Affect Schedule (PANAS)7-10 days

Momentary self-reports of the Positive and Negative Affect Schedule (PANAS) will be administered in a tablet-based application, which measures momentary positive and negative affect. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.

Visual Analog Scale (VAS)7-10 days

Momentary self-reports of the Visual Analog Scale (VAS) of depression, anxiety, and energy will be administered in a tablet-based application. These are fast self-reports to indicate the affect level along a line from none to prominent. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.

Hamilton Depression Rating Scales (HAMD-6)7-10 days

Momentary self-reports of Hamilton Depression Rating Scales (HAMD-6) will be administered in a tablet-based application, which is widely used to measure the severity of the depressive state. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.

Hamilton Anxiety Rating Scales (HAM-A)7-10 days

Momentary self-reports of Hamilton Anxiety Rating scales (HAM-A) will be administered in a tablet-based application, which is widely used to measure the severity of the anxiety state. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.

Immediate Mood Scalar (IMS)7-10 days

Momentary self-reports of the Immediate Mood Scalar (IMS) will be administered in a tablet-based application, which measures depression and anxiety severity. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.

Fear of Negative Evaluation Brief7-10 days

Momentary self-reports of Fear of Negative Evaluation Brief will be administered in a tablet-based application. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.

Secondary Outcome Measures
NameTimeMethod
Physiological measurements - heart rate variability (HRV)7-10 days

Heart rate variability will be collected from each participant by using either commercial systems or the new wearable sensor.

Physiological measurements - skin conductance (SC)7-10 days

Skin conductance will be collected from each participant by using either commercial systems or the new wearable sensor.

Physiological measurements - cortisol level7-10 days

Cortisol level will be collected from each participant by using either commercial systems or the new wearable sensor.

Neural measurements7-10 days

In epilepsy patients who already have intracranial EEG recordings for their standard clinical monitoring (unrelated to this study), we will also obtain iEEG activity measurements. EEG power will be the main focus of the analysis, but the raw signal will also be analyzed.

Trial Locations

Locations (2)

Rancho Los Amigos National Rehabilitation Center

🇺🇸

Downey, California, United States

University of Southern California

🇺🇸

Los Angeles, California, United States

Rancho Los Amigos National Rehabilitation Center
🇺🇸Downey, California, United States
Charles Liu, MD, PhD
Contact
323-226-7421
cliu@usc.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.